Annual Long Term Debt
$44.98 M
-$8.05 M-15.18%
31 December 2023
Summary:
Denali Therapeutics annual long term debt is currently $44.98 million, with the most recent change of -$8.05 million (-15.18%) on 31 December 2023. During the last 3 years, it has fallen by -$13.57 million (-23.18%). DNLI annual long term debt is now -34.68% below its all-time high of $68.86 million, reached on 31 December 2019.DNLI Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Long Term Debt
$44.48 M
+$3.50 M+8.54%
30 September 2024
Summary:
Denali Therapeutics quarterly long term debt is currently $44.48 million, with the most recent change of +$3.50 million (+8.54%) on 30 September 2024. Over the past year, it has dropped by -$500.00 thousand (-1.11%). DNLI quarterly long term debt is now -37.71% below its all-time high of $71.41 million, reached on 31 March 2019.DNLI Quarterly Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
DNLI Long Term Debt Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | -1.1% |
| 3 y3 years | -23.2% | -24.0% |
| 5 y5 years | -34.7% | -35.4% |
DNLI Long Term Debt High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -23.2% | at low | -24.0% | +8.5% |
| 5 y | 5 years | -34.7% | at low | -35.4% | +8.5% |
| alltime | all time | -34.7% | -37.7% |
Denali Therapeutics Long Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $44.48 M(+8.5%) |
| June 2024 | - | $40.98 M(-4.8%) |
| Mar 2024 | - | $43.03 M(-4.3%) |
| Dec 2023 | $44.98 M(-15.2%) | $44.98 M(-4.1%) |
| Sept 2023 | - | $46.89 M(-3.8%) |
| June 2023 | - | $48.75 M(-3.6%) |
| Mar 2023 | - | $50.55 M(-4.7%) |
| Dec 2022 | $53.03 M(-9.4%) | $53.03 M(-3.5%) |
| Sept 2022 | - | $54.98 M(-1.0%) |
| June 2022 | - | $55.52 M(-2.7%) |
| Mar 2022 | - | $57.09 M(-2.5%) |
| Dec 2021 | $58.55 M | $58.55 M(-2.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2021 | - | $59.99 M(-2.3%) |
| June 2021 | - | $61.40 M(-2.4%) |
| Mar 2021 | - | $62.92 M(-2.0%) |
| Dec 2020 | $64.17 M(-6.8%) | $64.17 M(-1.9%) |
| Sept 2020 | - | $65.41 M(-1.8%) |
| June 2020 | - | $66.61 M(-1.7%) |
| Mar 2020 | - | $67.79 M(-1.6%) |
| Dec 2019 | $68.86 M(>+9900.0%) | $68.86 M(-1.5%) |
| Sept 2019 | - | $69.92 M(-1.4%) |
| June 2019 | - | $70.91 M(-0.7%) |
| Mar 2019 | - | $71.41 M(>+9900.0%) |
| Dec 2018 | $0.00 | $0.00 |
FAQ
- What is Denali Therapeutics annual long term debt?
- What is the all time high annual long term debt for Denali Therapeutics?
- What is Denali Therapeutics quarterly long term debt?
- What is the all time high quarterly long term debt for Denali Therapeutics?
- What is Denali Therapeutics quarterly long term debt year-on-year change?
What is Denali Therapeutics annual long term debt?
The current annual long term debt of DNLI is $44.98 M
What is the all time high annual long term debt for Denali Therapeutics?
Denali Therapeutics all-time high annual long term debt is $68.86 M
What is Denali Therapeutics quarterly long term debt?
The current quarterly long term debt of DNLI is $44.48 M
What is the all time high quarterly long term debt for Denali Therapeutics?
Denali Therapeutics all-time high quarterly long term debt is $71.41 M
What is Denali Therapeutics quarterly long term debt year-on-year change?
Over the past year, DNLI quarterly long term debt has changed by -$500.00 K (-1.11%)